A comparison of strategies for switching patients from amitriptyline to duloxetine for the management of diabetic peripheral neuropathic pain
Latest Information Update: 16 Sep 2008
At a glance
- Drugs Duloxetine (Primary) ; Amitriptyline
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 02 Aug 2007 Status changed from in progress to completed.
- 24 Jul 2007 The expected completion date for this trial is now 1 Nov 2008.
- 27 Jan 2007 Status change